0 193

Cited 0 times in

Phase II study of sitravatinib in combination with tislelizumab in patients with advanced biliary tract cancer who have failed to at least 1 prior systemic treatment: Trial in progress

Authors
 Do-Youn Oh  ;  Jin Won Kim  ;  Hongjae Chon  ;  Choong-kun Lee  ;  Ji-Won Kim  ;  Beodeul Kang  ;  Hye Jin Choi  ;  Se Jun Park  ;  Jeesun Yoon  ;  Myung Ah Lee 
Citation
 JOURNAL OF CLINICAL ONCOLOGY, Vol.40(4 suppl) : TPS490, 2022-02 
Journal Title
JOURNAL OF CLINICAL ONCOLOGY
ISSN
 0732-183X 
Issue Date
2022-02
Full Text
https://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.TPS490
DOI
10.1200/JCO.2022.40.4_suppl.TPS490
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Kang, Beodeul(강버들) ORCID logo https://orcid.org/0000-0001-5177-8937
Lee, Choong-kun(이충근) ORCID logo https://orcid.org/0000-0001-5151-5096
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/194651
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links